phenanthridone has been researched along with Heart Disease, Ischemic in 1 studies
phenanthridone: coal tar derivative; structure given in first source
phenanthridone : A member of the class of phenanthridines that is phenanthridine with an oxo substituent at position 6. A poly(ADP-ribose) polymerase (PARP) inhibitor, it has been shown to exhibit immunosuppressive activity.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ferraris, D | 1 |
Ko, YS | 1 |
Pahutski, T | 1 |
Ficco, RP | 1 |
Serdyuk, L | 1 |
Alemu, C | 1 |
Bradford, C | 1 |
Chiou, T | 1 |
Hoover, R | 1 |
Huang, S | 1 |
Lautar, S | 1 |
Liang, S | 1 |
Lin, Q | 1 |
Lu, MX | 1 |
Mooney, M | 1 |
Morgan, L | 1 |
Qian, Y | 1 |
Tran, S | 1 |
Williams, LR | 1 |
Wu, QY | 1 |
Zhang, J | 1 |
Zou, Y | 1 |
Kalish, V | 1 |
1 other study available for phenanthridone and Heart Disease, Ischemic
Article | Year |
---|---|
Design and synthesis of poly ADP-ribose polymerase-1 inhibitors. 2. Biological evaluation of aza-5[H]-phenanthridin-6-ones as potent, aqueous-soluble compounds for the treatment of ischemic injuries.
Topics: Animals; Aza Compounds; Brain Ischemia; Dogs; Enzyme Inhibitors; Haplorhini; Humans; In Vitro Techni | 2003 |